Sponsor or institution
Clinical trials and research at Menzies School of Health Research
As of November 12, 2026, Find a Trial lists 5 clinical trials run by Menzies School of Health Research that are recruiting, at sites in 6 countries (most in Brazil (2), Ethiopia (2), Papua New Guinea (2)). By phase: Phase 4 (3), Phase 3 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 6Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Passive RSV antibody to protect Aboriginal and Torres Strait Islander infants | Phase 4 | Darwin, Northern Territory | Recruiting | May 11, 2026 |
| High-dose daily and weekly primaquine for vivax malaria in people with reduced G6PD activity | Phase 4 | Manaus and 3 other locations | Recruiting | Mar 12, 2026 |
| Pneumococcal Vaccine Test for severely malnourished kids in hospital | Phase 4 | Dili | Recruiting | Feb 10, 2025 |
| Revised tafenoquine dosing for treating vivax malaria | Phase 3 | Manaus and 3 other locations | Recruiting | Nov 28, 2023 |
| Improving culturally safe healthcare for Aboriginal patients | Phase 2 | Darwin, Northern Territory and 3 other locations | Recruiting | Nov 29, 2022 |
All recruiting trials (5)
-
Passive RSV antibody to protect Aboriginal and Torres Strait Islander infants
This trial tests whether giving a single shot of the RSV antibody nirsevimab to Aboriginal and Torres Strait Islander infants around 6 months old can reduce RSV infections in the first year of life.
-
High-dose daily and weekly primaquine for vivax malaria in people with reduced G6PD activity
This will test whether 1 mg/kg daily primaquine for 7 days is safe and works for adults with P. vivax and intermediate G6PD, and whether 0.75 mg/kg weekly primaquine is safe and works for adults with G6PD deficiency.
-
Pneumococcal Vaccine Test for severely malnourished kids in hospital
This study tests whether giving Pneumosil to children aged 6–59 months with severe acute malnutrition in hospital elicits a better immune response than a Typhoid vaccine, with follow-up visits over six months.
-
Revised tafenoquine dosing for treating vivax malaria
This study is testing a new weight-based dose of tafenoquine to see if it works as well or better than current treatments for people with vivax malaria.
-
Improving culturally safe healthcare for Aboriginal patients
This study is trying to see if training healthcare workers in cultural safety and using more Aboriginal interpreters can improve the hospital experience and health outcomes for Aboriginal patients in Northern Territory.
Quick answers
How many clinical trials run by Menzies School of Health Research are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in Brazil (2 trials), Ethiopia (2 trials), Papua New Guinea (2 trials), Australia (2 trials), Timor-Leste (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 3, Phase 3: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.